Literature DB >> 25219760

Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients.

Raynier Devillier1, Véronique Gelsi-Boyer, Anne Murati, Thomas Prebet, Jérôme Rey, Anne Etienne, Evelyne D'Incan, Aude Charbonnier, Didier Blaise, Marie-Joëlle Mozziconacci, Norbert Vey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25219760     DOI： 10.1002/ajh.23850

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  9 in total

1.  Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia.

Authors:  Olga K Weinberg; Olga Pozdnyakova; Federico Campigotto; Daniel J DeAngelo; Richard M Stone; Donna Neuberg; Robert P Hasserjian
Journal:  Mod Pathol       Date:  2015-05-15       Impact factor: 7.842

2.  Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.

Authors:  Raynier Devillier; Véronique Mansat-De Mas; Veronique Gelsi-Boyer; Cecile Demur; Anne Murati; Jill Corre; Thomas Prebet; Sarah Bertoli; Mandy Brecqueville; Christine Arnoulet; Christian Recher; Norbert Vey; Marie-Joelle Mozziconacci; Eric Delabesse; Daniel Birnbaum
Journal:  Oncotarget       Date:  2015-04-10

3.  NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML.

Authors:  Anne-Sophie Chretien; Raynier Devillier; Cyril Fauriat; Florence Orlanducci; Samia Harbi; Aude Le Roy; Jérôme Rey; Gaelle Bouvier Borg; Emmanuel Gautherot; Jean-François Hamel; Norbert Ifrah; Catherine Lacombe; Pascale Cornillet-Lefebvre; Jacques Delaunay; Antoine Toubert; Christine Arnoulet; Norbert Vey; Didier Blaise; Daniel Olive
Journal:  Oncoimmunology       Date:  2017-03-24       Impact factor: 8.110

4.  NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Authors:  Anne-Sophie Chretien; Cyril Fauriat; Florence Orlanducci; Jerome Rey; Gaelle Bouvier Borg; Emmanuel Gautherot; Samuel Granjeaud; Clemence Demerle; Jean-François Hamel; Adelheid Cerwenka; Elke Pogge von Strandmann; Norbert Ifrah; Catherine Lacombe; Pascale Cornillet-Lefebvre; Jacques Delaunay; Antoine Toubert; Christine Arnoulet; Norbert Vey; Daniel Olive
Journal:  Oncotarget       Date:  2017-07-25

5.  The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.

Authors:  Po-Shen Ko; Yao-Chung Liu; Chiu-Mei Yeh; Jyh-Pyng Gau; Yuan-Bin Yu; Liang-Tsai Hsiao; Cheng-Hwai Tzeng; Po-Min Chen; Tzeon-Jye Chiou; Chia-Jen Liu; Jin-Hwang Liu
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

6.  High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.

Authors:  Anne-Sophie Chretien; Raynier Devillier; Samuel Granjeaud; Charlotte Cordier; Clemence Demerle; Nassim Salem; Julia Wlosik; Florence Orlanducci; Laurent Gorvel; Stephane Fattori; Marie-Anne Hospital; Jihane Pakradouni; Emilie Gregori; Magali Paul; Philippe Rochigneux; Thomas Pagliardini; Mathieu Morey; Cyril Fauriat; Nicolas Dulphy; Antoine Toubert; Herve Luche; Marie Malissen; Didier Blaise; Jacques A Nunès; Norbert Vey; Daniel Olive
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

7.  Repositioning of bromocriptine for treatment of acute myeloid leukemia.

Authors:  María Carmen Lara-Castillo; Josep Maria Cornet-Masana; Amaia Etxabe; Antònia Banús-Mulet; Miguel Ángel Torrente; Meritxell Nomdedeu; Marina Díaz-Beyá; Jordi Esteve; Ruth M Risueño
Journal:  J Transl Med       Date:  2016-09-07       Impact factor: 5.531

8.  ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.

Authors:  Concepción Prats-Martín; Sergio Burillo-Sanz; Rosario M Morales-Camacho; Olga Pérez-López; Milagros Suito; Maria T Vargas; Teresa Caballero-Velázquez; Estrella Carrillo-Cruz; José González; Ricardo Bernal; José A Pérez-Simón
Journal:  Cancer Med       Date:  2020-03-26       Impact factor: 4.452

9.  Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients

Authors:  Lei Wang; Xiaoxia Chu; Jingyao Wang; Licai An; Yinghui Liu; Li Li; Junqing Xu
Journal:  Turk J Haematol       Date:  2021-05-03       Impact factor: 1.831
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.